Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C10H12N4O5S |
Molecular Weight | 300.291 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12CC(=O)N1[C@@H](C(O)=O)[C@](C)(CN3C=CN=N3)S2(=O)=O
InChI
InChIKey=LPQZKKCYTLCDGQ-WEDXCCLWSA-N
InChI=1S/C10H12N4O5S/c1-10(5-13-3-2-11-12-13)8(9(16)17)14-6(15)4-7(14)20(10,18)19/h2-3,7-8H,4-5H2,1H3,(H,16,17)/t7-,8+,10+/m1/s1
Molecular Formula | C10H12N4O5S |
Molecular Weight | 300.291 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:52:05 UTC 2023
by
admin
on
Fri Dec 15 15:52:05 UTC 2023
|
Record UNII |
SE10G96M8W
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
LIVERTOX |
NBK548825
Created by
admin on Fri Dec 15 15:52:05 UTC 2023 , Edited by admin on Fri Dec 15 15:52:05 UTC 2023
|
||
|
NDF-RT |
N0000175930
Created by
admin on Fri Dec 15 15:52:05 UTC 2023 , Edited by admin on Fri Dec 15 15:52:05 UTC 2023
|
||
|
NDF-RT |
N0000000202
Created by
admin on Fri Dec 15 15:52:05 UTC 2023 , Edited by admin on Fri Dec 15 15:52:05 UTC 2023
|
||
|
NCI_THESAURUS |
C1500
Created by
admin on Fri Dec 15 15:52:05 UTC 2023 , Edited by admin on Fri Dec 15 15:52:05 UTC 2023
|
||
|
WHO-ATC |
J01CG02
Created by
admin on Fri Dec 15 15:52:05 UTC 2023 , Edited by admin on Fri Dec 15 15:52:05 UTC 2023
|
||
|
WHO-ATC |
J01DH51
Created by
admin on Fri Dec 15 15:52:05 UTC 2023 , Edited by admin on Fri Dec 15 15:52:05 UTC 2023
|
||
|
WHO-VATC |
QJ01CG02
Created by
admin on Fri Dec 15 15:52:05 UTC 2023 , Edited by admin on Fri Dec 15 15:52:05 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
37617
Created by
admin on Fri Dec 15 15:52:05 UTC 2023 , Edited by admin on Fri Dec 15 15:52:05 UTC 2023
|
PRIMARY | RxNorm | ||
|
SE10G96M8W
Created by
admin on Fri Dec 15 15:52:05 UTC 2023 , Edited by admin on Fri Dec 15 15:52:05 UTC 2023
|
PRIMARY | |||
|
9421
Created by
admin on Fri Dec 15 15:52:05 UTC 2023 , Edited by admin on Fri Dec 15 15:52:05 UTC 2023
|
PRIMARY | |||
|
C62079
Created by
admin on Fri Dec 15 15:52:05 UTC 2023 , Edited by admin on Fri Dec 15 15:52:05 UTC 2023
|
PRIMARY | |||
|
89786-04-9
Created by
admin on Fri Dec 15 15:52:05 UTC 2023 , Edited by admin on Fri Dec 15 15:52:05 UTC 2023
|
PRIMARY | |||
|
TAZOBACTAM
Created by
admin on Fri Dec 15 15:52:05 UTC 2023 , Edited by admin on Fri Dec 15 15:52:05 UTC 2023
|
PRIMARY | |||
|
DB01606
Created by
admin on Fri Dec 15 15:52:05 UTC 2023 , Edited by admin on Fri Dec 15 15:52:05 UTC 2023
|
PRIMARY | |||
|
Ceftolozane and Tazobactam
Created by
admin on Fri Dec 15 15:52:05 UTC 2023 , Edited by admin on Fri Dec 15 15:52:05 UTC 2023
|
PRIMARY | |||
|
6340
Created by
admin on Fri Dec 15 15:52:05 UTC 2023 , Edited by admin on Fri Dec 15 15:52:05 UTC 2023
|
PRIMARY | |||
|
SE10G96M8W
Created by
admin on Fri Dec 15 15:52:05 UTC 2023 , Edited by admin on Fri Dec 15 15:52:05 UTC 2023
|
PRIMARY | |||
|
AA-6
Created by
admin on Fri Dec 15 15:52:05 UTC 2023 , Edited by admin on Fri Dec 15 15:52:05 UTC 2023
|
PRIMARY | |||
|
m10490
Created by
admin on Fri Dec 15 15:52:05 UTC 2023 , Edited by admin on Fri Dec 15 15:52:05 UTC 2023
|
PRIMARY | Merck Index | ||
|
C043265
Created by
admin on Fri Dec 15 15:52:05 UTC 2023 , Edited by admin on Fri Dec 15 15:52:05 UTC 2023
|
PRIMARY | |||
|
Piperacillin and Tazobactam
Created by
admin on Fri Dec 15 15:52:05 UTC 2023 , Edited by admin on Fri Dec 15 15:52:05 UTC 2023
|
PRIMARY | |||
|
123630
Created by
admin on Fri Dec 15 15:52:05 UTC 2023 , Edited by admin on Fri Dec 15 15:52:05 UTC 2023
|
PRIMARY | |||
|
SUB10849MIG
Created by
admin on Fri Dec 15 15:52:05 UTC 2023 , Edited by admin on Fri Dec 15 15:52:05 UTC 2023
|
PRIMARY | |||
|
DTXSID8023634
Created by
admin on Fri Dec 15 15:52:05 UTC 2023 , Edited by admin on Fri Dec 15 15:52:05 UTC 2023
|
PRIMARY | |||
|
CHEMBL404
Created by
admin on Fri Dec 15 15:52:05 UTC 2023 , Edited by admin on Fri Dec 15 15:52:05 UTC 2023
|
PRIMARY | |||
|
759887
Created by
admin on Fri Dec 15 15:52:05 UTC 2023 , Edited by admin on Fri Dec 15 15:52:05 UTC 2023
|
PRIMARY | |||
|
2572
Created by
admin on Fri Dec 15 15:52:05 UTC 2023 , Edited by admin on Fri Dec 15 15:52:05 UTC 2023
|
PRIMARY | |||
|
100000091983
Created by
admin on Fri Dec 15 15:52:05 UTC 2023 , Edited by admin on Fri Dec 15 15:52:05 UTC 2023
|
PRIMARY | |||
|
1643383
Created by
admin on Fri Dec 15 15:52:05 UTC 2023 , Edited by admin on Fri Dec 15 15:52:05 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SOLVATE->ANHYDROUS | |||
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (HPLC)
USP
|
||
|
SALT/SOLVATE -> PARENT | |||
|
EXCRETED UNCHANGED |
URINE
|
||
|
SALT/SOLVATE -> PARENT | |||
|
BINDER->LIGAND |
The protein binding of either piperacillin or tazobactam is unaffected by the presence of the other compound.
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Biological Half-life | PHARMACOKINETIC |
|
|
|||